Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Maintains $113 Price Target
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar has maintained an 'In-Line' rating and a $113 price target for Zimmer Biomet Holdings (NYSE:ZBH).
September 05, 2024 | 5:25 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Evercore ISI Group has reiterated its 'In-Line' rating and $113 price target for Zimmer Biomet Holdings, indicating a neutral stance on the stock.
The reaffirmation of the 'In-Line' rating and price target suggests that the analyst sees no immediate catalysts for significant price movement. This neutral stance implies that the stock is expected to perform in line with the market.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100